Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Mr. Pink's Picks: selected event-driven value investments -- Ignore unavailable to you. Want to Upgrade?

To: Mr. Pink who wrote (14828)	2/10/2001 11:55:36 PM
From: RockyBalboa	Respond to of 18998

Hello, Mr P$nk, Nice to see you back on S.I., it is always a pleasure to follow your ideas...not only a pleasure. It pays off, too! on emcor, any triggers impending? By the way the earlier reports about Buffett having bought CNC bonds turned out to be bogus; CNC off since. Message 15315788

To: Mr. Pink who wrote (14828)	2/11/2001 3:21:38 AM
From: 200ma	Read Replies (2) \| Respond to of 18998

what does t3/f mean?

To: Mr. Pink who wrote (14828)	2/11/2001 3:56:02 PM
From: Jack Hartmann	Respond to of 18998

EMKR balance sheet troubling to you, I take it? Some old EMKR DD in December Message 15037725 Regards, Jack

To: Mr. Pink who wrote (14828)	2/12/2001 8:19:45 PM
From: StockDung	Respond to of 18998

RE SEXI and Ted Melcher. Truthseeker exposes the CRIMS Message 15341580

To: Mr. Pink who wrote (14828)	2/13/2001 12:53:11 AM
From: Pink Minion	Respond to of 18998

Mr. P$nk, in His infinite wisdom initiates coverage on EMKR rated T3/F A T3/F??? It looks like another overvalued fiber play. Throw a dart. A T3/F sounds like accounting problems? Fraud? Can't say?

To: Mr. Pink who wrote (14828)	2/14/2001 1:57:51 AM
From: 200ma	Respond to of 18998

Mr pink what do you think of GP as a value/asset play?

To: Mr. Pink who wrote (14828)	2/14/2001 8:18:02 AM
From: Mr_X	Read Replies (1) \| Respond to of 18998

Mr. P#$K, Welcome back! I have been paralyzed in your absense. Pleased to have you back safe and sound and not adversely affected by the Earthquake. Conseco - Are you pleased to find fraud allegations in this mornings papers? May this be the catalyst to push the stock back to the $4-5 level from todays absurd prices. I hope Irwin shokes on his breakfast when he reads this stuff. Mr. X

To: Mr. Pink who wrote (14828)	2/16/2001 2:20:53 PM
From: StockDung	Read Replies (2) \| Respond to of 18998

BioPulse's Tijuana Cancer Clinic Shut Down by Mexican Officials San Diego, Feb. 16 (Bloomberg) -- BioPulse International Inc.'s controversial Tijuana cancer clinic was shut down yesterday by Baja California state health officials, two weeks after the U.S. Federal Trade Commission told the company it is investigating claims BioPulse makes to attract patients. The clinic provides more than 90 percent of the company's revenue, according to its regulatory filings. Revenue for the fiscal year ended July 31, 2000 was $3.1 million. ``Yesterday, we made the inspection and we found out that the clinic was advertising and offering cancer treatments that aren't authorized,'' said Alfredo Gruel, head of regulation at the state's Public Health Service Institute. ``They are applying procedures that are not authorized in Mexico.'' Without mentioning the closure, BioPulse issued a press release today saying it will sell the Tijuana facility's assets. Company executives weren't immediately available for comment. The clinic's treatments, which the company has declared are unproven, include inducing daily comas in patients and injecting patients with vaccines made from their own urine. Gruel said the clinic didn't have a license to conduct such procedures as inducing comas. The closure did not affect homeopathic treatments at the clinic. Those procedures are properly licensed, officials said. BioPulse has also been banned from advertising its cancer treatment operations, said Gruel. He said he expects the company to file a complaint and seek an injunction against the state actions. Mexico also bans companies from testing experimental procedures, even when they have disclosed to the patient the nature of the treatment and its experimental stage. ``In Mexico you can't do experimental treatments, unless you have a permit from the authorities,'' said Gruel. BioPulse publicist John Liviakis promotes BioPulse on his Web site, lfcent.com./biopulse.html, as ``enjoying high success rates in treating cancer and other diseases.'' A recent SEC filing by the company appeared to contradict its own spokesman. ``To date, none of our technologies have proven effective, been submitted for or received FDA approval for marketing in the United States,'' the company said. Last month, Bloomberg News reported that some U.S. cancer experts were concerned that BioPulse's treatments, besides being ineffective, could harm patients. The clinic charges patients $5,700 a week, although it accepts other forms of payment. In October, it treated a woman in exchange for her father providing a $225,000 loan to BioPulse, according to a recent regulatory filing. Feb/16/2001 13:27 ET For more stories from Bloomberg News, click here. (C) Copyright 2001 Bloomberg L.P. cccccccccccccccccccccccc